Rossari Biotech Future Growth
Future criteria checks 4/6
Rossari Biotech is forecast to grow earnings and revenue by 22.3% and 16.6% per annum respectively. EPS is expected to grow by 22.3% per annum. Return on equity is forecast to be 15.4% in 3 years.
Key information
22.3%
Earnings growth rate
22.3%
EPS growth rate
| Chemicals earnings growth | 22.8% |
| Revenue growth rate | 16.6% |
| Future return on equity | 15.4% |
| Analyst coverage | Low |
| Last updated | 23 Oct 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 3/31/2027 | 28,895 | 2,388 | 1,624 | 2,222 | 3 |
| 3/31/2026 | 24,403 | 1,871 | 1,080 | 2,015 | 4 |
| 3/31/2025 | 20,636 | 1,496 | 586 | 2,355 | 4 |
| 9/30/2024 | 19,245 | 1,388 | 17 | 1,162 | N/A |
| 6/30/2024 | 19,096 | 1,364 | N/A | N/A | N/A |
| 3/31/2024 | 18,306 | 1,307 | -880 | 433 | N/A |
| 12/31/2023 | 17,643 | 1,255 | N/A | N/A | N/A |
| 9/30/2023 | 16,898 | 1,168 | -341 | 631 | N/A |
| 6/30/2023 | 16,318 | 1,078 | N/A | N/A | N/A |
| 3/31/2023 | 16,559 | 1,073 | 1,187 | 1,516 | N/A |
| 12/31/2022 | 16,883 | 1,027 | N/A | N/A | N/A |
| 9/30/2022 | 17,275 | 995 | 729 | 990 | N/A |
| 6/30/2022 | 16,866 | 1,018 | N/A | N/A | N/A |
| 3/31/2022 | 14,830 | 977 | -89 | 294 | N/A |
| 12/31/2021 | 12,623 | 957 | N/A | N/A | N/A |
| 9/30/2021 | 10,438 | 948 | -342 | 129 | N/A |
| 6/30/2021 | 8,310 | 892 | N/A | N/A | N/A |
| 3/31/2021 | 7,093 | 802 | -103 | 478 | N/A |
| 12/31/2020 | 6,507 | 729 | N/A | N/A | N/A |
| 9/30/2020 | 6,031 | 695 | 198 | 1,045 | N/A |
| 6/30/2020 | 5,818 | 666 | N/A | N/A | N/A |
| 3/31/2020 | 6,001 | 653 | -191 | 568 | N/A |
| 3/31/2019 | 5,162 | 457 | 272 | 712 | N/A |
| 3/31/2018 | 2,922 | 254 | N/A | 254 | N/A |
| 3/31/2017 | 2,350 | 143 | N/A | 67 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 543213's forecast earnings growth (22.3% per year) is above the savings rate (6.7%).
Earnings vs Market: 543213's earnings (22.3% per year) are forecast to grow faster than the Indian market (18% per year).
High Growth Earnings: 543213's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 543213's revenue (16.6% per year) is forecast to grow faster than the Indian market (10.5% per year).
High Growth Revenue: 543213's revenue (16.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 543213's Return on Equity is forecast to be low in 3 years time (15.4%).